RecruitingPhase 2NCT04066296

Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine

Sponsor

University of Colorado, Denver

Enrollment

100 participants

Start Date

Sep 8, 2019

Study Type

INTERVENTIONAL

Conditions

Lumbar Spinal Stenosis

Summary

Evaluate the benefit of using liposomal bupivicaine in lumbar laminectomies in terms of length of stay, IV narcotic use, 30-day narcotic use, visual analog score (VAS) and 30-day readmissions

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Male or Female
Adult (≥18 yo)
Lumbar stenosis

Exclusion Criteria9

Co-morbidities precluding surgery
≤18 yo
Pregnant
Breastfeeding
Need for instrumented fusion
Prisoners
Intra-operative CSF leak (identified by gush of CSF)
Daily pre-operative opioid use of > 25 morphine Eq/day
Previous lumbar surgery at indicated level

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLiposomal bupivacaine

Injection of either liposomal bupivicaine or standard local anesthetic during surgical procedure.

Locations(1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04066296

Related Trials

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT030729272284 locations

Comparative Analysis of Two Transforaminal Lumbar Interbody Fusion (TLIF) Procedures in the Treatment of Single-Level Lumbar Spinal Stenosis (LSS): A Single-Center, Prospective, Randomized Controlled Trial

NCT075885551 location